Konstantin Poukalov's Insider Trades & SAST Disclosures
Konstantin Poukalov's most recent trade in Lyra Therapeutics Inc was a trade of 30,000 Stock Option done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Konstantin Poukalov.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| LianBio - ADR | Konstantin Poukalov | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 36,300 | 0 | - | - | Stock Option (Right to Buy) | |
| LianBio - ADR | Poukalov Konstantin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.52 per share. | 15 Feb 2024 | 36,300 | 36,300 | - | 2.5 | 91,476 | Ordinary Shares |
| LianBio - ADR | Poukalov Konstantin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 15 Feb 2024 | 19,218 | 17,082 | - | 4.8 | 91,478 | Ordinary Shares |
| Lyra Therapeutics Inc | Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | 08 Feb 2021 | 13,369,728 | 13,369,728 | - | - | Common Stock | ||
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | 08 Feb 2021 | 7,486,190 | 0 | - | - | Series B Preferred Stock | ||
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | 08 Feb 2021 | 5,883,538 | 0 | - | - | Series A Preferred Stock | ||
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 08 Feb 2021 | 1,250,000 | 14,619,728 | - | 16 | 20,000,000 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.53 per share. | 05 Feb 2021 | 86,671 | 14,768,463 | - | 12.5 | 1,085,988 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.80 per share. | 05 Feb 2021 | 64,730 | 14,834,964 | - | 13.8 | 893,274 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.60 per share. | 05 Feb 2021 | 34,951 | 14,869,915 | - | 14.6 | 510,285 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.38 per share. | 05 Feb 2021 | 34,611 | 14,681,792 | - | 11.4 | 393,873 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.14 per share. | 05 Feb 2021 | 27,453 | 14,647,181 | - | 11.1 | 305,826 | Common Stock |
| Landos Biopharma Inc | Konstantin Poukalov | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.10 per share. | 05 Feb 2021 | 1,771 | 14,770,234 | - | 13.1 | 23,200 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges